Carmell (CTCX) Stock Price, News & Analysis

Company Overview

Carmell Corporation operates as a bio-aesthetics company. The company utilizes Carmell Secretome to support skin and hair health. Its Carmell Secretome consists of growth factors and proteins extracted from allogeneic human platelets sourced from tissue banks. The company also developed a microemulsion formulation that enables delivery of lipophilic and hydrophilic ingredients without relying on the Foul Fourteen, 14 potentially harmful excipients that are commonly used by other companies to impart texture, stability, and other desirable physicochemical attributes to cosmetic products. In addition, the company is also developing a line of men's products and a line of topical haircare products. It has licensing agreement with Carnegie Mellon University to develop and commercialize biocompatible plasma-based plastics. The company was formerly known as Carmell Therapeutics Corporation and changed its name to Carmell Corporation in November 2023. Carmell Therapeutics Corporation was founded in 2008 and is headquartered in Pittsburgh, Pennsylvania.

Key Stats

• Today's Range: $2.38 to $2.50
• 50-Day Range: $0.13 to $3.74
• 52-Week Range: $0.17 to $1.98
• Volume: 18,767 shs
• Average Volume: 4.29 million shs
• Market Capitalization: $51.22 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

CTCX Stock Analysis - Frequently Asked Questions

How have CTCX shares performed this year?

Carmell's stock was trading at $0.2791 on January 1st, 2025. Since then, CTCX shares have increased by 777.8% and is now trading at $2.45.

How do I buy shares of Carmell?

Shares of CTCX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Carmell own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Carmell investors own include Sangamo Therapeutics (SGMO), abrdn Asia-Pacific Income Fund (FAX), MSP Recovery (LIFW), Meta Platforms (META), NVIDIA (NVDA), Blue Owl Capital (OBDC) and Tenax Therapeutics (TENX).

Company Calendar

• Today: 7/04/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: Surgical & medical instruments
• Sub-Industry: Medical Equipment
• Current Symbol: NASDAQ:CTCX
• CIK: 1842939
• Web: www.carmellrx.com
• Phone: 412-894-8248
• Fax: N/A
• Employees: 14
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$15.44 million
• Net Margins: N/A
• Pretax Margin: -29,527.27%
• Return on Equity: -217.50%
• Return on Assets: -50.22%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 0.31
• Quick Ratio: 0.29

Sales & Book Value

• Annual Sales: $32.84 thousand
• Price / Sales: 1,559.65
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $1.07 per share
• Price / Book: 2.29

Miscellaneous

• Outstanding Shares: 20,905,000
• Free Float: 14,843,000
• Market Cap: $51.22 million
• Optionable: Not Optionable
• Beta: 0.51